» Articles » PMID: 35574856

ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress

Abstract

Background: Cellular redox control is maintained by generation of reactive oxygen/nitrogen species balanced by activation of antioxidative pathways. Disruption of redox balance leads to oxidative stress, a central causative event in numerous diseases including heart failure. Redox control in the heart exposed to hemodynamic stress, however, remains to be fully elucidated.

Methods: Pressure overload was triggered by transverse aortic constriction in mice. Transcriptomic and metabolomic regulations were evaluated by RNA-sequencing and metabolomics, respectively. Stable isotope tracer labeling experiments were conducted to determine metabolic flux in vitro. Neonatal rat ventricular myocytes and H9c2 cells were used to examine molecular mechanisms.

Results: We show that production of cardiomyocyte NADPH, a key factor in redox regulation, is decreased in pressure overload-induced heart failure. As a consequence, the level of reduced glutathione is downregulated, a change associated with fibrosis and cardiomyopathy. We report that the pentose phosphate pathway and mitochondrial serine/glycine/folate metabolic signaling, 2 NADPH-generating pathways in the cytosol and mitochondria, respectively, are induced by transverse aortic constriction. We identify ATF4 (activating transcription factor 4) as an upstream transcription factor controlling the expression of multiple enzymes in these 2 pathways. Consistently, joint pathway analysis of transcriptomic and metabolomic data reveal that ATF4 preferably controls oxidative stress and redox-related pathways. Overexpression of ATF4 in neonatal rat ventricular myocytes increases NADPH-producing enzymes' whereas silencing of ATF4 decreases their expression. Further, stable isotope tracer experiments reveal that ATF4 overexpression augments metabolic flux within these 2 pathways. In vivo, cardiomyocyte-specific deletion of ATF4 exacerbates cardiomyopathy in the setting of transverse aortic constriction and accelerates heart failure development, attributable, at least in part, to an inability to increase the expression of NADPH-generating enzymes.

Conclusions: Our findings reveal that ATF4 plays a critical role in the heart under conditions of hemodynamic stress by governing both cytosolic and mitochondrial production of NADPH.

Citing Articles

Dipeptidyl peptidase-4 deficiency prevents chronic stress-induced cardiac remodeling and dysfunction in mice.

Jiang Z, Zhao L, Xin M, Wan Y, Xu S, Yue X FASEB J. 2025; 39(4):e70398.

PMID: 39968759 PMC: 11836924. DOI: 10.1096/fj.202402328R.


Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases.

Jie H, Zhang J, Wu S, Yu L, Li S, Dong B Front Pharmacol. 2025; 15:1503824.

PMID: 39867658 PMC: 11757639. DOI: 10.3389/fphar.2024.1503824.


eIF2α phosphorylation-ATF4 axis-mediated transcriptional reprogramming mitigates mitochondrial impairment during ER stress.

Thi Le H, Yu J, Ahn H, Kim M, Chae I, Cho H Mol Cells. 2025; 48(2):100176.

PMID: 39756584 PMC: 11786836. DOI: 10.1016/j.mocell.2024.100176.


Decoding aging in the heart via single cell dual omics of non-cardiomyocytes.

Song Y, Wang L, Wang H, Ma H, Xu J, Liu J iScience. 2024; 27(12):111469.

PMID: 39735437 PMC: 11681900. DOI: 10.1016/j.isci.2024.111469.


Role of MTH1 in oxidative stress and therapeutic targeting of cancer.

Taiyab A, Ashraf A, Sulaimani M, Rathi A, Shamsi A, Hassan M Redox Biol. 2024; 77:103394.

PMID: 39418911 PMC: 11532495. DOI: 10.1016/j.redox.2024.103394.


References
1.
Doughan A, Harrison D, Dikalov S . Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2007; 102(4):488-96. DOI: 10.1161/CIRCRESAHA.107.162800. View

2.
Vanhoutte D, Schips T, Vo A, Grimes K, Baldwin T, Brody M . Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun. 2021; 12(1):3928. PMC: 8225674. DOI: 10.1038/s41467-021-24215-4. View

3.
Tran D, Kesavan R, Rion H, Soflaee M, Solmonson A, Bezwada D . Mitochondrial NADP is essential for proline biosynthesis during cell growth. Nat Metab. 2021; 3(4):571-585. PMC: 9210447. DOI: 10.1038/s42255-021-00374-y. View

4.
Ying W . NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal. 2007; 10(2):179-206. DOI: 10.1089/ars.2007.1672. View

5.
Gelinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A . AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nat Commun. 2018; 9(1):374. PMC: 5785516. DOI: 10.1038/s41467-017-02795-4. View